1. Home
  2. SGU vs NPCE Comparison

SGU vs NPCE Comparison

Compare SGU & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SGU

Star Group L.P.

HOLD

Current Price

$12.78

Market Cap

431.4M

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$14.74

Market Cap

490.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGU
NPCE
Founded
1995
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
431.4M
490.2M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
SGU
NPCE
Price
$12.78
$14.74
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$18.33
AVG Volume (30 Days)
17.6K
103.8K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
5.90%
N/A
EPS Growth
N/A
29.03
EPS
N/A
N/A
Revenue
$1,784,418,000.00
$99,986,000.00
Revenue This Year
N/A
$0.90
Revenue Next Year
N/A
$24.46
P/E Ratio
$6.70
N/A
Revenue Growth
N/A
25.13
52 Week Low
$11.39
$9.22
52 Week High
$13.53
$19.60

Technical Indicators

Market Signals
Indicator
SGU
NPCE
Relative Strength Index (RSI) 54.25 51.53
Support Level $12.77 $13.76
Resistance Level $12.95 $14.72
Average True Range (ATR) 0.17 0.52
MACD 0.00 0.03
Stochastic Oscillator 59.09 44.83

Price Performance

Historical Comparison
SGU
NPCE

About SGU Star Group L.P.

Star Group LP is a home heating oil and propane distributor and services provider with one reportable operating segment that principally provides heating related services to residential and commercial customers. It serves residential and commercial customers whose primary use is to heat their homes and buildings in the Northeast and Mid-Atlantic U.S. regions. The company derives the majority of revenue from Petroleum products, which consist of home heating oil and propane as well as diesel fuel and gasoline.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: